Indoco Remedies announced that USFDA has retained the Official Action Initiated (OAI) status for Goa Plant - I (Finished Dosage Facility) of the company.

The facility was inspected by the USFDA in January 2019.

The plant currently supplies against one approved ANDA and has four ANDAs pending for approval.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)